OBR Daily Commentary

forumImage

NCCN Guidelines Emphasize Patient Preference as Key to Selection of Maintenance Therapy in Follicular Lymphoma

(NCCN) Sept 14, 2011 - Despite a long natural history and high response to therapy, relapse is to be expected in patients with follicular lymphoma.

Read Article arrow

Winston Wong, PharmD (Posted: September 15, 2011)

quotesIs this just a headline? Shouldn't the patient ultimately have the final decision as to the treatment provided after being presented with the treatment options? In many cases, I think the problem really is that the patient is not always presented with the all of the pros and cons of the various treatment options to make an informed decision.quotes

Add Comment 2 Comment
forumImage

NSAID Painkillers Linked to Risk of Kidney Cancer

(U.S. News & World Report) Sept 12, 2011 - The long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) such as Advil, Motrin and Aleve may slightly increase the risk for developing kidney cancer, Harvard researchers report.

Read Article arrow

Winston Wong, PharmD (Posted: September 13, 2011)

quotesThe key statement here is that this is "food for thought". The key question is how great is that increased risk to the general population that takes these medications. My guess is that the increase in risk is very low. The study noted 333 cases of cancer, but what was the population size that was followed? My fear is that primary care physicians will read this headline, and steer their patients off the NSAIDs to other medications, which will then cause other problems. At the end of the day, what have we gained?quotes

Add Comment 2 Comment
forumImage

Warning Over Global Cancer Levels

(BBC News) Sept 7, 2011 - The number of new cancer cases has increased by 20% in under a decade and now stands at 12 million a year, according to the World Cancer Research Fund.

Read Article arrow

Winston Wong, PharmD (Posted: September 07, 2011)

quotesIs it really an increase in the incidence of cancer, or we simply getting better at detection? I suspect it is a little of both.quotes

Add Comment 1 Comment

Meet the Editorial Board

Community Oncology
member photo
Dean Gesme, MD

FACP FACPE FASCO President, Minnesota Oncology...

Breast Cancer
member photo
Debu Tripathy, MD

Professor and Chair, Department of Breast Medical Oncol...

Lung Cancer
member photo
H. Jack West, MD

Medical Director, Thoracic Oncology Program, Swedish Ca...

Gastrointestinal Cancers
member photo
Howard S. Hochster, MD

Associate Cancer Center Director, Yale Cancer Center P...

Community Oncology
member photo
Jeff Patton, M.D.

CEO Tennessee Oncology...

Precision Medicine Section Editor
member photo
Jennifer Levin Carter, MD, MPH

Chief Medical Officer and Founder, N-of-One...

Financial Sector
member photo
Michael G. King Jr.

Managing Director and Senior Biotechnology Analyst...

Gastrointestinal Cancers
member photo
Richard Goldberg, MD

Director WVU Cancer Institute Director of Cancer Signa...

Editor-In-Chief
member photo
Robert A. Figlin, MD., FACP

Professor and Director, Division of Hematology Oncology...

Health Policy
member photo
Ted Okon

Executive Director Community Oncology Alliance...

Community Oncology
member photo
Thomas Marsland, MD

Vice President Integrated Community Oncology Network ...

Community Oncology
member photo
William Harwin MD

Florida Cancer Specialists President and Managing Part...

Health Policy
member photo
William McGivney, PhD

National Health Policy Expert...

Payer
member photo
Winston Wong, PharmD

President, W-Squared Group...